Weight loss in middle age improves heart health; PCOS linked to Alzheimer’s risk
Studies show 5% weight loss in middle age can reduce heart disease risk, while metabolic issues in PCOS may raise Alzheimer’s risk.
Key facts
- University College London study of 6,000 UK 1958 cohort found 5% weight loss in 40s and 50s led to similar cholesterol, blood pressure, and inflammation levels by age 62 as those who were always healthy weight.
- The study noted that losing 5% of body weight may reduce inflammation and lower stroke risk.
- Journal of the Endocrine Society review found metabolic conditions associated with PMOS, such as insulin resistance, obesity, type 2 diabetes, and high cholesterol, may explain a potential link to Alzheimer’s disease.
- The review identified mild differences in brain structure and function in people with PMOS, but differences were less pronounced when compared to metabolically healthy controls.
A University College London study followed 6,000 people born in 1958. Researchers found that those who lost 5% of their weight in their 40s and 50s had similar cholesterol, blood pressure, and inflammation levels by age 62 as people who had always been healthy weight. The study used body mass index data and measured cardiovascular markers. The authors said modest weight loss can reverse some age‑related health decline.
The researchers noted that losing just 5% of body weight may reduce inflammation and lower stroke risk. They said the change could improve quality of life and reduce heart disease risk. The study suggested prevention efforts should target people in their 50s. The lead author, Charis Bridger‑Staatz, said it is never too late to start making changes.
A review published in the Journal of the Endocrine Society examined studies on polyendocrine metabolic ovarian syndrome (PMOS), formerly PCOS. The review found that metabolic conditions associated with PMOS, such as insulin resistance, obesity, type 2 diabetes, and high cholesterol, may explain a potential link to Alzheimer’s disease. The authors searched PubMed for studies through 2025. They identified mild differences in brain structure and function in people with PMOS.
The review noted that differences were less pronounced when people with PMOS were compared to metabolically healthy controls. The authors suggested that underlying metabolic issues may play a key role. They said the review does not prove that PMOS causes Alzheimer’s disease. The review called for more research.
Both studies highlight the importance of metabolic health for long‑term outcomes. They show that small lifestyle changes can have significant benefits. They also show that metabolic disorders can affect both heart and brain health.
Context
Weight gain is common as people age, and it can strain cardiovascular health. Metabolic conditions such as insulin resistance, obesity, and high cholesterol are linked to brain health. Understanding these links can guide prevention strategies.
How outlets headlined it
How this was made
Compiled by our AI newsroom from 2 independent outlets, checked by a separate AI editor against the sources. Only claims found in the sources are reported. Spot an error? Every source is linked below.
Correction or source request? simoneggert16@gmail.com
Open reader debate: Factual contributions and additions are synchronized directly in real time across all readers.
Loading contributions from cloud server…
Reader Discussion & Community Notes